Rosiglitazone and PPAR-γ overexpression protect mitochondrial membrane and prevent mitochondria-mediated apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.

Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's disease

Martin, Heather L.
Mounsey, Ross B.
Mustafa, Sarah
Sathe, Kinnari
Teismann, Peter

June 2012

AbstractPeroxisome proliferator-activated receptor γ (PPARγ) agonists have been shown to provide neu...

Adiponectin and macrophage-associated Irak3 are indispensable molecules in the anti-atherosclerotic properties of PPAR agonists.

Maarten Hulsmans (181118)
Benjamine Geeraert (187732)
Thierry Arnould (122707)
Christos Tsatsanis (187751)
Paul Holvoet (122610)

April 2013

The schematic draw demonstrates the anti-atherosclerotic properties of the PPARγ agonist rosiglit...

• BRIEF REPORTS • Effect of ligand of peroxisome proliferator-activated receptor γ on the biological characters of hepatic stellate cells

Yan-tong Guo
Xi-sheng Leng
Tao Li
Ji-run Peng
Sheng-han Song
Liang-fa Xiong
Zhi-zhong Qin
Yan-tong Guo
Xi-sheng Leng
Tao Li
Ji-run Peng

October 2015

AIM: To study the effect of rosiglitazone, which is a ligand of peroxisome proliferator-activated re...

Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins

Wu, JS

[[abstract]]To determine the involvement of peroxisome proliferator-activated receptor-gamma (PPAR-g...

Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production

강은석
김수경
심완섭
안철우
이현철
정태우
차봉수

January 2007

1-Methyl-4-phenylpyridinium ion (MPP+), an inhibitor of mitochondrial complex I, has been widely use...

[[alternative]]Ligand-Activated Peroxisome Proliferator-Activated Receptor-gamma Protects Against Ischemic Cerebral Infarction and Neuronal Apoptosis by 14-3-3 is an element of Upregulation

Wu, JS

[[abstract]]Background-Thiazolidinediones have been reported to protect against ischemia-reperfusion...

Rosiglitazone protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity

강은석
안철우
이현철
차봉수

January 2006

Acetaldehyde, an inhibitor of mitochondrial function, has been widely used as a neurotoxin because i...

PPAR-gamma activation attenuates deltamethrin-induced apoptosis by regulating cytosolic PINK1 and inhibiting mitochondrial dysfunction

��

October 2016

Central events in the mitochondrial-dependent cell death pathway include the disruption of mitochond...

Ligand-Activated Peroxisome Proliferator-Activated Receptor- Protects Against Ischemic Cerebral Infarction and Neuronal Apoptosis by 14-3-3 Upregulation

Wu, Jui Sheng
Cheung, Wai Mui
Tsai, Yau Sheng
Chen, Yi Tong
Fong, Wen Hsuan
Tsai, Hsin Da
Chen, Yu Chang
Liou, Jun Yang
Shyue, Song Kun
Chen, Jin Jer
Chen, Y. Eugene
Maeda, Nobuyo
Wu, Kenneth K.
Lin, Teng Nan

January 2009

Thiazolidinediones (TZD) were reported to protect against ischemia-reperfusion (I/R) injury. Their p...

Ligand-activated PPAR-γ protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3ε upregulation.

Wu, JS

[[sponsorship]]生物醫學科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/...

Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells

Meshkani, R.
Sadeghi, A.
Taheripak, G.
Zarghooni, M.
Gerayesh-Nejad, S.
Bakhtiyari, S.

January 2014

Palmitate induces insulin resistance and apoptosis in insulin target tissues. Rosiglitazone (RSG), a...

Activation of Peroxisome Proliferator-Activated Receptor γ by Rosiglitazone Inhibits Lipopolysaccharide-Induced Release of High Mobility Group Box 1

Jung Seok Hwang
Eun Sil Kang
Sun Ah Ham
Taesik Yoo
Hanna Lee
Kyung Shin Paek
Chankyu Park
Jin-Hoi Kim
Dae-Seog Lim
Han Geuk Seo

January 2012

Peroxisome proliferator-activated receptors (PPARs) are shown to modulate the pathological status of...

Rosiglitazone Regulates Anti-Inflammation and Growth Inhibition via PTEN

Chiou-Feng Lin
Kung-Chia Young
Chyi-Huey Bai
Bu-Chin Yu
Ching-Ting Ma
Yu-Chieh Chien
Chiu-Ling Chiang
Chao-Sheng Liao
Hsin-Wen Lai
Chiung-Wen Tsao

January 2014

Peroxisome proliferator-activated receptor gamma (PPARγ) agonist has anti-inflammatory and anticance...

A potential involvement of PPARγ in apoptosis induced by combination of rosiglitazone and LA-12.

Jarmila Lauková (817112)
Alois Kozubík (2740675)
Jiřina Hofmanová (817113)
Jana Nekvindová (5665555)
Petr Sova (817114)
Mary Pat Moyer (257775)
Jiří Ehrmann (5665558)
Alena Hyršlová Vaculová (817115)

October 2015

(a) Cleavage of caspase-9, caspase-3, PARP (Western blotting), and (b) caspase-3 activation (flow...

FAM3A mediates PPAR gamma's protection in liver ischemia-reperfusion injury by activating Akt survival pathway and repressing inflammation and oxidative stress

Chen, Zhenzhen
Wang, Junpei
Yang, Weili
Chen, Ji
Meng, Yuhong
Geng, Bin
Cui, Qinghua
Yang, Jichun

January 2017

FAM3A is a novel mitochondrial protein, and its biological function remains largely unknown. This st...

Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's disease

Martin, Heather L.
Mounsey, Ross B.
Mustafa, Sarah
Sathe, Kinnari
Teismann, Peter

June 2012

AbstractPeroxisome proliferator-activated receptor γ (PPARγ) agonists have been shown to provide neu...

Adiponectin and macrophage-associated Irak3 are indispensable molecules in the anti-atherosclerotic properties of PPAR agonists.

Maarten Hulsmans (181118)
Benjamine Geeraert (187732)
Thierry Arnould (122707)
Christos Tsatsanis (187751)
Paul Holvoet (122610)

April 2013

The schematic draw demonstrates the anti-atherosclerotic properties of the PPARγ agonist rosiglit...

• BRIEF REPORTS • Effect of ligand of peroxisome proliferator-activated receptor γ on the biological characters of hepatic stellate cells

Yan-tong Guo
Xi-sheng Leng
Tao Li
Ji-run Peng
Sheng-han Song
Liang-fa Xiong
Zhi-zhong Qin
Yan-tong Guo
Xi-sheng Leng
Tao Li
Ji-run Peng

October 2015

AIM: To study the effect of rosiglitazone, which is a ligand of peroxisome proliferator-activated re...

Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins

Wu, JS

[[abstract]]To determine the involvement of peroxisome proliferator-activated receptor-gamma (PPAR-g...

Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production

강은석
김수경
심완섭
안철우
이현철
정태우
차봉수

January 2007

1-Methyl-4-phenylpyridinium ion (MPP+), an inhibitor of mitochondrial complex I, has been widely use...

[[alternative]]Ligand-Activated Peroxisome Proliferator-Activated Receptor-gamma Protects Against Ischemic Cerebral Infarction and Neuronal Apoptosis by 14-3-3 is an element of Upregulation

Wu, JS

[[abstract]]Background-Thiazolidinediones have been reported to protect against ischemia-reperfusion...

Rosiglitazone protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity

강은석
안철우
이현철
차봉수

January 2006

Acetaldehyde, an inhibitor of mitochondrial function, has been widely used as a neurotoxin because i...

PPAR-gamma activation attenuates deltamethrin-induced apoptosis by regulating cytosolic PINK1 and inhibiting mitochondrial dysfunction

��

October 2016

Central events in the mitochondrial-dependent cell death pathway include the disruption of mitochond...

Ligand-Activated Peroxisome Proliferator-Activated Receptor- Protects Against Ischemic Cerebral Infarction and Neuronal Apoptosis by 14-3-3 Upregulation

Wu, Jui Sheng
Cheung, Wai Mui
Tsai, Yau Sheng
Chen, Yi Tong
Fong, Wen Hsuan
Tsai, Hsin Da
Chen, Yu Chang
Liou, Jun Yang
Shyue, Song Kun
Chen, Jin Jer
Chen, Y. Eugene
Maeda, Nobuyo
Wu, Kenneth K.
Lin, Teng Nan

January 2009

Thiazolidinediones (TZD) were reported to protect against ischemia-reperfusion (I/R) injury. Their p...

Ligand-activated PPAR-γ protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3ε upregulation.

Wu, JS

[[sponsorship]]生物醫學科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/...

Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells

Meshkani, R.
Sadeghi, A.
Taheripak, G.
Zarghooni, M.
Gerayesh-Nejad, S.
Bakhtiyari, S.

January 2014

Palmitate induces insulin resistance and apoptosis in insulin target tissues. Rosiglitazone (RSG), a...

Activation of Peroxisome Proliferator-Activated Receptor γ by Rosiglitazone Inhibits Lipopolysaccharide-Induced Release of High Mobility Group Box 1

Jung Seok Hwang
Eun Sil Kang
Sun Ah Ham
Taesik Yoo
Hanna Lee
Kyung Shin Paek
Chankyu Park
Jin-Hoi Kim
Dae-Seog Lim
Han Geuk Seo

January 2012

Peroxisome proliferator-activated receptors (PPARs) are shown to modulate the pathological status of...

Rosiglitazone Regulates Anti-Inflammation and Growth Inhibition via PTEN

Chiou-Feng Lin
Kung-Chia Young
Chyi-Huey Bai
Bu-Chin Yu
Ching-Ting Ma
Yu-Chieh Chien
Chiu-Ling Chiang
Chao-Sheng Liao
Hsin-Wen Lai
Chiung-Wen Tsao

January 2014

Peroxisome proliferator-activated receptor gamma (PPARγ) agonist has anti-inflammatory and anticance...

A potential involvement of PPARγ in apoptosis induced by combination of rosiglitazone and LA-12.

Jarmila Lauková (817112)
Alois Kozubík (2740675)
Jiřina Hofmanová (817113)
Jana Nekvindová (5665555)
Petr Sova (817114)
Mary Pat Moyer (257775)
Jiří Ehrmann (5665558)
Alena Hyršlová Vaculová (817115)

October 2015

(a) Cleavage of caspase-9, caspase-3, PARP (Western blotting), and (b) caspase-3 activation (flow...

FAM3A mediates PPAR gamma's protection in liver ischemia-reperfusion injury by activating Akt survival pathway and repressing inflammation and oxidative stress

Chen, Zhenzhen
Wang, Junpei
Yang, Weili
Chen, Ji
Meng, Yuhong
Geng, Bin
Cui, Qinghua
Yang, Jichun

January 2017

FAM3A is a novel mitochondrial protein, and its biological function remains largely unknown. This st...

Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's disease

Martin, Heather L.
Mounsey, Ross B.
Mustafa, Sarah
Sathe, Kinnari
Teismann, Peter

June 2012

AbstractPeroxisome proliferator-activated receptor γ (PPARγ) agonists have been shown to provide neu...

Adiponectin and macrophage-associated Irak3 are indispensable molecules in the anti-atherosclerotic properties of PPAR agonists.

Maarten Hulsmans (181118)
Benjamine Geeraert (187732)
Thierry Arnould (122707)
Christos Tsatsanis (187751)
Paul Holvoet (122610)

April 2013

The schematic draw demonstrates the anti-atherosclerotic properties of the PPARγ agonist rosiglit...

• BRIEF REPORTS • Effect of ligand of peroxisome proliferator-activated receptor γ on the biological characters of hepatic stellate cells

Yan-tong Guo
Xi-sheng Leng
Tao Li
Ji-run Peng
Sheng-han Song
Liang-fa Xiong
Zhi-zhong Qin
Yan-tong Guo
Xi-sheng Leng
Tao Li
Ji-run Peng

October 2015

AIM: To study the effect of rosiglitazone, which is a ligand of peroxisome proliferator-activated re...

Rosiglitazone and PPAR-γ overexpression protect mitochondrial membrane and prevent mitochondria-mediated apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.

Abstract

Extracted data

Rosiglitazone and PPAR-γ overexpression protect mitochondrial membrane and prevent mitochondria-mediated apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.

Abstract

Extracted data

Related items

Related items